• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory.MERS-CoV 感染的人口统计学变异:利雅得地区实验室基于实验室数据的流行病学分析。
Biomed Res Int. 2020 Feb 19;2020:9629747. doi: 10.1155/2020/9629747. eCollection 2020.
2
Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study.沙特阿拉伯中东呼吸综合征冠状病毒疫情:一项回顾性研究。
BMC Infect Dis. 2017 Jan 5;17(1):23. doi: 10.1186/s12879-016-2137-3.
3
Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.早期识别在沙特阿拉伯感染中东呼吸综合征冠状病毒感染风险增加的肺炎患者。
Int J Infect Dis. 2018 May;70:51-56. doi: 10.1016/j.ijid.2018.03.005. Epub 2018 Mar 14.
4
Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.中东呼吸综合征冠状病毒(MERS-CoV)在海湾阿拉伯国家合作委员会各国的出现:四年期更新情况
PLoS One. 2017 Oct 13;12(10):e0183850. doi: 10.1371/journal.pone.0183850. eCollection 2017.
5
Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015.2012年至2015年沙特阿拉伯中东呼吸综合征冠状病毒疫情病例与非疫情病例的病例特征
BMJ Open. 2017 Jan 12;7(1):e011865. doi: 10.1136/bmjopen-2016-011865.
6
CPMPARISON between COVID-19 and MERS demographic data in Saudi Arabia: a retrospective study.比较 COVID-19 和 MERS 在沙特阿拉伯的人口统计学数据:一项回顾性研究。
Libyan J Med. 2021 Dec;16(1):1910195. doi: 10.1080/19932820.2021.1910195.
7
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.沙特阿拉伯中东呼吸综合征冠状病毒抗体的存在情况:一项全国性横断面血清学研究。
Lancet Infect Dis. 2015 May;15(5):559-64. doi: 10.1016/S1473-3099(15)70090-3. Epub 2015 Apr 8.
8
Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015.英国对从中东返回的旅行者和朝圣者进行中东呼吸综合征冠状病毒主动筛查和监测:2013 - 2015年期间的一项前瞻性描述性研究
Int J Infect Dis. 2016 Jun;47:10-4. doi: 10.1016/j.ijid.2016.04.016. Epub 2016 Apr 23.
9
Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study.医院患者及其医护人员和家庭接触者中东呼吸综合征冠状病毒感染的筛查:一项前瞻性描述性研究。
Clin Microbiol Infect. 2014 May;20(5):469-74. doi: 10.1111/1469-0691.12562. Epub 2014 Feb 17.
10
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.

引用本文的文献

1
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies.SARS-CoV-2 变异株的进化:对免疫逃逸、疫苗接种、治疗和诊断策略的影响。
Viruses. 2023 Apr 10;15(4):944. doi: 10.3390/v15040944.
2
Immunochromatographic and microscopic detection of Plasmodium falciparum in recipients of P. falciparum-infected donor blood.免疫层析和显微镜检测接受疟原虫感染供体血液者的疟原虫 falciparum。
Parasitol Res. 2022 May;121(5):1455-1465. doi: 10.1007/s00436-022-07476-w. Epub 2022 Mar 1.
3
The Recent Technologies to Curb the Second-Wave of COVID-19 Pandemic.遏制新冠疫情第二波的最新技术
IEEE Access. 2021 Jul 2;9:97906-97928. doi: 10.1109/ACCESS.2021.3094400. eCollection 2021.
4
Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19.理解新型冠状病毒爆发对吸毒人群的影响:为应对 COVID-19 提供实践和毒品政策响应的系统评价。
Int J Environ Res Public Health. 2021 Aug 11;18(16):8470. doi: 10.3390/ijerph18168470.
5
Gender Specific Differences in Disease Susceptibility: The Role of Epigenetics.疾病易感性中的性别特异性差异:表观遗传学的作用。
Biomedicines. 2021 Jun 8;9(6):652. doi: 10.3390/biomedicines9060652.
6
Geographical trend analysis of COVID-19 pandemic onset in Africa.非洲新冠疫情爆发的地理趋势分析。
Soc Sci Humanit Open. 2021;4(1):100137. doi: 10.1016/j.ssaho.2021.100137. Epub 2021 Mar 4.
7
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions.SARS-CoV-2,SARS-CoV 和 MERS-CoV 的另一面:未来预测。
Biomed J. 2021 Mar;44(1):86-93. doi: 10.1016/j.bj.2020.10.008. Epub 2020 Oct 28.
8
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives.过去四十年的病毒性大流行:发病机制、健康影响和展望。
Int J Environ Res Public Health. 2020 Dec 15;17(24):9411. doi: 10.3390/ijerph17249411.
9
Middle East Respiratory Syndrome (MERS) and novel coronavirus disease-2019 (COVID-19): From causes to preventions in Saudi Arabia.中东呼吸综合征(MERS)与2019新型冠状病毒病(COVID-19):沙特阿拉伯的病因与预防措施
Saudi Pharm J. 2020 Nov;28(11):1481-1491. doi: 10.1016/j.jsps.2020.09.014. Epub 2020 Sep 24.
10
Early geography of the coronavirus disease outbreak in Nigeria.尼日利亚冠状病毒病疫情的早期地理分布情况。
GeoJournal. 2022;87(2):733-747. doi: 10.1007/s10708-020-10278-1. Epub 2020 Aug 13.

本文引用的文献

1
Middle East respiratory syndrome coronavirus (MERS-CoV): Impact on Saudi Arabia, 2015.中东呼吸综合征冠状病毒(MERS-CoV):2015年对沙特阿拉伯的影响
Saudi J Biol Sci. 2018 Nov;25(7):1402-1405. doi: 10.1016/j.sjbs.2016.09.020. Epub 2016 Oct 1.
2
Underlying trend, seasonality, prediction, forecasting and the contribution of risk factors: an analysis of globally reported cases of Middle East Respiratory Syndrome Coronavirus.潜在趋势、季节性、预测、预报以及危险因素的作用:对全球报告的中东呼吸综合征冠状病毒病例的分析。
Epidemiol Infect. 2018 Aug;146(11):1343-1349. doi: 10.1017/S0950268818001541. Epub 2018 Jun 11.
3
Development of a risk-prediction model for Middle East respiratory syndrome coronavirus infection in dialysis patients.透析患者中东呼吸综合征冠状病毒感染风险预测模型的开发
Hemodial Int. 2018 Oct;22(4):474-479. doi: 10.1111/hdi.12661. Epub 2018 Apr 14.
4
Estimating survival rates in MERS-CoV patients 14 and 45 days after experiencing symptoms and determining the differences in survival rates by demographic data, disease characteristics and regions: a worldwide study.估计 MERS-CoV 患者在出现症状后 14 天和 45 天的生存率,并根据人口统计学数据、疾病特征和地区确定生存率的差异:一项全球性研究。
Epidemiol Infect. 2018 Mar;146(4):489-495. doi: 10.1017/S095026881700293X. Epub 2017 Dec 22.
5
Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.中东呼吸综合征冠状病毒(MERS-CoV)在海湾阿拉伯国家合作委员会各国的出现:四年期更新情况
PLoS One. 2017 Oct 13;12(10):e0183850. doi: 10.1371/journal.pone.0183850. eCollection 2017.
6
The predictors of 3- and 30-day mortality in 660 MERS-CoV patients.660例中东呼吸综合征冠状病毒(MERS-CoV)患者3天和30天死亡率的预测因素。
BMC Infect Dis. 2017 Sep 11;17(1):615. doi: 10.1186/s12879-017-2712-2.
7
Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study.中东呼吸综合征危重症患者:一项多中心回顾性队列研究
Crit Care Med. 2017 Oct;45(10):1683-1695. doi: 10.1097/CCM.0000000000002621.
8
Diagnostic delays in 537 symptomatic cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.沙特阿拉伯537例中东呼吸综合征冠状病毒感染症状性病例的诊断延误情况。
Int J Infect Dis. 2017 Sep;62:47-51. doi: 10.1016/j.ijid.2017.07.008. Epub 2017 Jul 17.
9
Clinical validation of 3 commercial real-time reverse transcriptase polymerase chain reaction assays for the detection of Middle East respiratory syndrome coronavirus from upper respiratory tract specimens.三种用于从上呼吸道标本中检测中东呼吸综合征冠状病毒的商用实时逆转录聚合酶链反应检测方法的临床验证
Diagn Microbiol Infect Dis. 2017 Apr;87(4):320-324. doi: 10.1016/j.diagmicrobio.2017.01.003. Epub 2017 Jan 10.
10
A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes.中东呼吸综合征冠状病毒或其他病因导致的急性呼吸道疾病住院患者的临床表现及不良结局危险因素的比较研究
PLoS One. 2016 Nov 3;11(11):e0165978. doi: 10.1371/journal.pone.0165978. eCollection 2016.

MERS-CoV 感染的人口统计学变异:利雅得地区实验室基于实验室数据的流行病学分析。

Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory.

机构信息

College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

National Health Laboratory, Saudi Center for Disease Prevention and Control (Saudi CDC), Riyadh, Saudi Arabia.

出版信息

Biomed Res Int. 2020 Feb 19;2020:9629747. doi: 10.1155/2020/9629747. eCollection 2020.

DOI:10.1155/2020/9629747
PMID:32149148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7049846/
Abstract

UNLABELLED

. Middle East respiratory syndrome coronavirus was first recognized in September 2012 in Saudi Arabia. The clinical presentations of MERS and non-MERS SARI are often similar. Therefore, the identification of suspected cases that may have higher chances of being diagnosed as cases of MERS-CoV is essential. However, the real challenge is to flag these patients through some demographic markers. The nature of these markers has not previously been investigated in Saudi Arabia, and hence, this study aims to identify them.

METHODS

It was a surveillance system-based study, for which data from a total of 23,646 suspected patients in Riyadh and Al Qassim regions were analyzed from January 2017 until December 2017 to estimate the prevalence of MERS-CoV among suspected cases and to determine potential demographic risk factors related to the confirmation of the diagnosis.

RESULTS

Of 23,646 suspected cases, 119 (0.5%) were confirmed by laboratory results. These confirmed cases (67.2% of which were males) had a mean age of 43.23 years (SD ± 22.8). Around 42.2% of the confirmed cases were aged between 41 and 60 years and about 47% of confirmed cases had their suspected specimen tested in the summer. The study identified three significant and independent predictors for confirmation of the disease: an age between 41 and 60 years, male gender, and summer season admission.

CONCLUSION

The study provides evidence that the MERS-CoV epidemic in the subject regions has specific characteristics that might help future plans for the prevention and management of such a contagious disease. Future studies should aim to confirm such findings in other regions of Saudi Arabia as well and explore potential preventable risk factors.

摘要

目的

. 中东呼吸综合征冠状病毒于 2012 年 9 月在沙特阿拉伯首次被发现。MERS 和非 MERS SARS 的临床症状通常相似。因此,识别可能更有可能被诊断为 MERS-CoV 病例的疑似病例至关重要。然而,真正的挑战是通过一些人口统计学标记来标记这些患者。这些标记的性质以前在沙特阿拉伯尚未进行过研究,因此,本研究旨在确定这些标记。

方法

这是一项基于监测系统的研究,对 2017 年 1 月至 2017 年 12 月期间利雅得和盖西姆地区的总共 23646 例疑似患者的数据进行了分析,以估计 MERS-CoV 在疑似病例中的流行率,并确定与确诊相关的潜在人口统计学危险因素。

结果

在 23646 例疑似病例中,有 119 例(0.5%)通过实验室结果得到证实。这些确诊病例(其中 67.2%为男性)的平均年龄为 43.23 岁(标准差±22.8)。约 42.2%的确诊病例年龄在 41 至 60 岁之间,约 47%的确诊病例疑似样本在夏季进行了检测。研究确定了三个对确诊疾病有重要且独立的预测因素:年龄在 41 至 60 岁之间、男性和夏季入院。

结论

本研究提供了证据表明,在研究地区的 MERS-CoV 流行具有特定特征,这可能有助于未来制定预防和管理此类传染病的计划。未来的研究应旨在在沙特阿拉伯的其他地区证实这些发现,并探讨潜在的可预防危险因素。